Literature DB >> 3163147

Concomitant transcriptional and post-transcriptional control of mRNA abundance during human myeloid cell differentiation.

S V Graham1, G D Birnie.   

Abstract

The mechanisms controlling the expression of two genes during the differentiation of HL60 cells have been studied. The relative abundance of one mRNA, designated 2B5, increases during retinoic acid-induced differentiation; this increase can be accounted for, in part at least, by a marked increase in the rate of transcription of the gene. The relative abundance of the second, pCG56, decreases during retinoic acid-induced differentiation although the rate of transcription of this gene also increases during the course of differentiation. The bulk of pCG56 transcripts, though polyadenylated and apparently fully processed, are located in the nuclei of the uninduced cells, but on the polysomes of the induced cells. The data indicate that the change in the expression of the gene encoding pCG56 RNA is regulated differently from that encoding 2B5 RNA, and are interpreted as evidence that the pCG56 gene is regulated by an interaction between transcriptional and post-transcriptional controls. Furthermore, the latter includes both mRNA stability and a post-transcriptional mechanism that has not previously been demonstrated in differentiating cells, viz. nucleo-cytoplasmic transport of mRNA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3163147      PMCID: PMC336387          DOI: 10.1093/nar/16.6.2523

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  22 in total

1.  Biosynthesis and stability of globin mRNA in cultured erythroleukemic Friend cells.

Authors:  H Aviv; Z Voloch; R Bastos; S Levy
Journal:  Cell       Date:  1976-08       Impact factor: 41.582

2.  Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture.

Authors:  S J Collins; R C Gallo; R E Gallagher
Journal:  Nature       Date:  1977-11-24       Impact factor: 49.962

3.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

4.  Transcriptional regulation of hemoglobin switching in chicken embryos.

Authors:  M Groudine; M Peretz; H Weintraub
Journal:  Mol Cell Biol       Date:  1981-03       Impact factor: 4.272

5.  Use of synthetic oligonucleotides as hybridization probes: isolation of cloned cDNA sequences for human beta 2-microglobulin.

Authors:  S V Suggs; R B Wallace; T Hirose; E H Kawashima; K Itakura
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

6.  The rabbit beta-globin gene contains a large large insert in the coding sequence.

Authors:  A J Jeffreys; R A Flavell
Journal:  Cell       Date:  1977-12       Impact factor: 41.582

7.  Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester.

Authors:  G Rovera; D Santoli; C Damsky
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

8.  Prolactin-mediated transcriptional and post-transcriptional control of casein gene expression.

Authors:  W A Guyette; R J Matusik; J M Rosen
Journal:  Cell       Date:  1979-08       Impact factor: 41.582

9.  Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.

Authors:  T R Breitman; S E Selonick; S J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

10.  Differences among the polyadenylated RNA sequences of human leucocyte populations: an approach to the objective classification of human leukaemias.

Authors:  L M Wiedemann; J H Burns; G D Birnie
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  1 in total

Review 1.  The HL60 cell line: a model system for studying human myeloid cell differentiation.

Authors:  G D Birnie
Journal:  Br J Cancer Suppl       Date:  1988-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.